Skip to content
Thursday, January 15, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Tulsa’s Jewish community pushes back on Oklahoma Jewish charter school proposal January 15, 2026
  • Travel disrupted, fears elevated as Israel weathers uncertainty over potential US strike on Iran January 15, 2026
  • Deborah Lipstadt has second thoughts about tying Jackson synagogue arsonist to ‘Globalize the Intifada’ January 14, 2026
  • ‘They Let Us Burn’ — Tensions Run High as Los Angeles Marks One Year Since the Palisades and Eaton Fires January 14, 2026
  • Militant pro-Israel group Betar US to halt NY operations after settlement with state attorney general January 13, 2026
  • Rubble of Pasadena synagogue destroyed in wildfire is vandalized with anti-Zionist graffiti January 13, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.